Characterization of the inoculum effect with Haemophilus influenzae and β-lactams

Diagnostic Microbiology and Infectious Disease

Volumn 33, Issue 1, 1999, Pages 47-58

  Balko, Tamara ^a,b   Karlowsky, James A ^c   Palatnick, Lorraine P ^b   Zhanel, George G ^a,b   Hoban, Daryl J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c JAK LPP GGZ AJH) Hlth Sci Ctr ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFUROXIME;

ARTICLE; HAEMOPHILUS INFLUENZAE; INOCULATION; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TURBIDITY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CLAVULANIC ACID; COLONY COUNT, MICROBIAL; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0032972344     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00117-5     Document Type: Article

References (44)

1. Alexander H.E., Leidy G. Determination of inherited traits of H. influenzae by deoxyribonucleic acid fractions isolated from type-specific cells. J Exp Med. 93:1951;345-359.
2. Amsterdam D (1991)Susceptibility testing of antimicrobials in liquid media, In: Antibiotics in Laboratory Medicine, 3rd ed. V. Ed, Lorian V, Baltimore. The Williams & Willkins Co. pp 53-105.
3. Anderson E.L., Robinson P.A., Tu K.K., Adams C.R. β-lactamase-positive strains of Haemophilus influenzae Susceptibility to and inactivation of β-lactam antibiotics . South Med J. 78:1985;643-646.
4. Ausulbel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (Ed) (1994) Current Protocols in Molecular Biology New York: John Wiley and Sons, section 1.8.4.
5. Barak G.J., Chandler M.S., Redfield R.J., Tomb J.F. Genetic systems in Haemophilus influenzae. Methods Enzymol. 204:1991;321-341.
6. Bill N.J., Washington J.A. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor. Antimicrob Agents Chemother. 11:1977;470-474.
7. Bottone E.J., Brandman Z., Schneierson S. Spheroplasts of Haemophilus influenzae induced by cell wall-active antibiotics and their effect upon the interpretation of susceptibility tests. Antimicrob Agents Chemother. 9:1976;327-333.
8. Brook I. Inoculum effect. Rev Infect Dis. 11:1989;361-368.
9. Bryan LE, Godfrey AJ (1991) β-lactam antibiotics: Mode of action and bacterial resistance. Antibiotics in Laboratory Medicine, 3rd ed. In: Ed, Lorian V. Williams & Willkins, Baltimore: pp. 599-643.
10. Bulger R.R., Washington J.A. II. Effect of inoculum size and β-lactamase production on in vitro activity of new cephalosporins against Haemophilus species. Antimicrob Agents Chemother. 17:1980;393-396.
11. Bush K. Characterization of β-lactamases. Antimicrob Agents Chemother. 33:1989;259-263.
12. Bush K. Classification of β-lactamases Group 1, 2a, 2b, and 2b' . Antimicrob Agents Chemother. 33:1989;264-270.
13. Campos J.M., Gill C.J., Ahonkhai V.I. In-vitro activity of imipenem against 100 strains of serotype b and nontypable Haemophilus influenzae, including strains resistant to ampicillin, chloramphenicol or both. J Antimicrob Chemother. 16:1985;549-554.
14. Daum R.S., Murphey-Corb M., Shapira E., Dipp S. Epidemiology of Rob β-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States. J Infect Dis. 157:1988;450-455.
15. Doern G.V., Brueggemann A.B., Pierce G., Holley H.P. Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate Results of a national multicenter surveillance study . Antimicrob Agents Chemother. 41:1997;292-297.
16. Draum R.S., Murphey-Corb M., Shapira E., Dipp S. Epidemiology of Rob β-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States. J Infect Dis. 157:1988;450-455.
17. Feldman W.E. Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis. J Pediatr. 88:1976;549-552.
18. Gaya H., Hutchinson G.R., Chadwick M.V. In vitro activity of temocillin against Gram-negative clinical isolates. Drugs. 29:(suppl 5):1985;15-17.
19. Gordon R.C., Wofford-McQueen R., Shu K. In vitro synergism of rifampin-cephalosporin combinations against Haemophilus influenzae type b. Eur J Clin Microbiol Infect Dis. 9:1990;201-205.
20. Johnson C.C., Gold M.J., Pitsakis P.G., Taylor S., Levison M.E. Activity of cefepime against ceftazidime-resistant Gram-negative bacilli using high and low inocula. J Antimicrob Chemother. 35:1995;765-773.
21. Jorgensen J.H. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis. 14:1992;1119-1123.
22. Jorgensen J.H., Doern G.V., Maher L.A., Howell A.W., Redding J.S. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 34:1990;2075-2080.
23. Juteau J.M., Levesque R.C. Sequence analysis and evolutionary perspectives of ROB-1 β-lactamase. Antimicrob Agents Chemother. 34:1990;1354-1359.
24. Knapp C.C., Sierra-Madero J., Washington J.A. Antimicrobial activities of cefpodoxime, cefixime, and ceftriaxone. Antimicrob Agents Chemother. 32:1988;1896-1898.
25. Laferriere C., Marks M.I., Welch D.F. Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics. Antimicrob Agents Chemother. 24:1983;287-289.
26. Levin R.M., Parvin H.A., Dunphy M.C. Susceptibility of Haemophilus influenzae type b to cefaclor and influence of inoculum size. Antimicrob Agents Chemother. 22:1982;923-925.
27. Lipuma J.J., Daley B., Stull T.L. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b. J Antimicrob Chemother. 25:1990;535-539.
28. MacIver I., Silverman S.H., Brown M.R.W., O'Reilly T. Rat model of chronic lung infections caused by non-typable Haemophilus influenzae. J Med Microbiol. 35:1991;139-147.
29. National Committee for Clinical Laboratory Standards (1993) Methods for Dilutions Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; M7-A4. vol. 17 no. 2. Villanova PA: NCCLS.
30. National Committee for Clinical Laboratory Standards (1994) Performance Standards Antimicrobial Susceptibility Testing, 5th Informational Supplement Volume 14 Number 16. Villanova PA: NCCLS.
31. Roberts D.E., Ingold A., Want S.V., May J.M. Osmotically stable L forms of Haemophilus influenzae and their significance in testing sensitivity to penicillins. J Clin Pathol. 27:1974;560-564.
32. Rubin L.G., Yolken R.H., Medeiros A.A., Moxon E.R. Ampicillin treatment failure of apparently β-lactamase negative Haemophilus influenzae type b meningitis due to a novel β-lactamase. Lancet. ii:1981;1008-1010.
33. Scriver S.R., Walmsley S.L., Kau C.L., Hoban D.J., Brunton J., McGeer A., Moore T.C., Witwicki E., Low D.E. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases. Antimicrob Agents Chemother. 38:1994;1678-1680.
34. Simard P., Bergeron M.G. Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms. J Antimicrob Chemother. 10:1982;397-402.
35. Sinai R., Hammerberg S., Marks M.I., Pai C.H. In vitro susceptibility of Haemophilus influenzae to sulfamethoxadole-trimethoprim and cefaclor, cephalexim, and cephradine. Antimicrob Agents Chemother. 13:1978;861-864.
36. Sutcliffe J.G. Nucleotide sequence of the ampicilin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci USA. 75:1978;3737-3741.
37. Sykes R.B., Matthew M., O'Callaghan C.H. R-factor mediated beta-lactamase production by Haemophilus influenzae. J Med Microbiol. 8:1975;437-441.
38. Syriopoulou V.P., Scheifele D.W., Sack C.M., Smith A.L. Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother. 16:1979;510-513.
39. Tenover F.C., Huang M.B., Rasheed J.K., Persing D.H. Development of PCR assays to detect ampicillin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae. J Clin Microbiol. 32:1994;2729-2737.
40. Vachon V., Lyew D.J., Coulton J.W. Transmembrane permeability channels across the outer membrane of Haemophilus influenzae type b. J Bacteriol. 162:1985;918-924.
41. Wilson P.J., Albitron W.L., Slaney L.S., Setlow J.K. Characterization of a multiple antibiotic resistance plasmid from Haemophilus ducreyi. Antimicrob Agents Chemother. 33:1989;1627-1630.
42. Yu P.K.W., Washington J.A. II. Bactericidal activity of cefoperazone with CP-45,899 against large inocula of β-lactamase-producing Haemophilus influenzae. Antimicrob Agents Chemother. 20:1981;63-65.
43. Zhanel GG, Karlowsky JA, Palatnick L, Weshnoweski B, Preston D, Hoban DJ (1995) Oral β-lactam antibiotics exhibit an inoculum effect against β-lactamase positive and β-lactamase negative H. influenzae, (abstr. E151). In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, p. 112.
44. Zhanel G.G., Crampton J., Kim S., Nicolle L.E., Davidson R.J., Hoban D.J. Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect. Chemotherapy. 38:1992;388-394.